-->

Company Registry

Acenxion Biosystems Inc
Profile last edited on: 6/10/2022

Enabling fast access to Phenotypic AST results
Year Founded
2020
First SBIR Year
2021
Latest SBIR Award
2022
Program Status
Active

WikiProfile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

2002 West 39th Avenue Suite 1004
Kansas City, KS 66103
   N/A
   N/A
   www.acxbio.com~acenxionbiosystems.com
Multiple Locations:   
Congressional District:   03
County:   Wyandotte

Public Profile

The scalable, automated AST system offered by Acenxion Biosystems is designed seamlessly to fit into current clinical workflows and to reduce time required for phenotypic AST results from days to just hours. This serves to allow clinicians rapid use of a targeted treatment thereby minimizing antibiotic exposure to AMR pressures.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
---
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount Project Title
2022 2 NIH $1,934,394
An automated, scalable, and rapid AST system for Gonorrhea STIs

Key People / Management

  Roy R Swiger -- CEO

  Andrew Isakson -- Director of Product Development

  Sachidevi Puttaswamy -- Director of Systems Integration

  Brian Struchtemeyer --

SBIR firms in the news

There are no news available.